Abstract:Schistosomiasis, a disease caused by blood flukes of the genus <em>Schistosoma</em>, belongs to the neglected tropical diseases. Left untreated, schistosomiasis can lead to severe health problems and even death. An estimated 800 million people are at risk of schistosomiasis and 250 million people are infected. The global strategy to control and eliminate schistosomiasis emphasizes large-scale preventive chemotherapy with praziquantel targeting school-age children. Other tools are available, such as information, education, and communication (IEC), improved access to water, sanitation, and hygiene (WASH), and snail control. Despite available evidence of the effectiveness of these control measures, analyses estimating the most cost-effective control or elimination strategies are scarce, inaccurate, and lack standardization. We systematically reviewed the literature on costs related to public health interventions against schistosomiasis to strengthen the current evidence-base.In adherence to the PRISMA guidelines, we systematically searched three readily available electronic databases (i.e., PubMed, WHOLIS, and ISI Web of Science) from inception to April 2019 with no language restrictions. Relevant documents were screened, duplicates eliminated, specific rules on studies to consider were defined, and the eligible studies fully reviewed. Costs of schistosomiasis interventions were classified in three groups: (i) preventive chemotherapy; (ii) preventive chemotherapy plus an individual diagnostic test to identify at-risk population; and (iii) test-and-treat interventions.Fifteen articles met our inclusion criteria. In general, it was hard to compare the reported costs from the different studies due to different approaches used to estimate and classify the costs of the intervention assessed. Costs varied considerably from one study to another, ranging from US$ 0.06 to US$ 4.46 per person treated. The difference between financial and opportunity costs only played a minimal role in the explanation of the costs' variation, even if delivery costs were two times higher in the analyses including economic costs. Most of the studies identified in our systematic review focused on sub-Saharan African countries.The degree of transparency of most of the costing studies of schistosomiasis interventions found in the current review was limited. Hence, there is a pressing need for strategies to improve the quality of cost analyses, and higher reporting standards and transparency that should be fostered by peer-review journal policies. Cost information on these interventions is crucial to inform resource allocation decisions and those regarding the affordability of scaling-up interventions.Schistosomiasis is one of about 20 neglected tropical diseases. It affects millions of people mainly in poor settings in African countries. The global strategy to control and eliminate schistosomiasis emphasizes large-scale preventive chemotherapy with praziquantel targeting school-age children. Evidence of the effectiveness of these control measures is largely available, while less is known about the costs of their implementation. We systematically reviewed the literature and analyzed studies that estimated costs of schistosomiasis interventions. We summarized the available evidence in three intervention groups: (i) preventive chemotherapy; (ii) preventive chemotherapy plus an individual diagnostic test to identify at-risk population; and (iii) test-and-treat interventions. Costs were overall hard to compare and varied considerably from one study to another. There is a need for higher reporting standards and transparency that should be fostered by peer-review journal policies. Cost information on these interventions is crucial to inform resource allocation decisions and those regarding the affordability of scaling-up interventions.

Cost-effectiveness analysis on screening for surveillance of schistosomiasis among population in transmission interrupted areas

Cost-effectiveness of Different Intervention Strategies of HIV in Zhejiang, China.

Elimination Of Schistosoma Japonicum Transmission In China: A Case Of Schistosomiasis Control In The Severe Epidemic Area Of Anhui Province

Effectiveness of the new integrated strategy to control the transmission of Schistosoma japonicum in China: a systematic review and meta-analysis.

National Surveillance of Schistosomiasis in China from 2000 to 2004

Evaluation of mid-term effectiveness of medium-and-long-term programme for prevention and control of schistosomiasis in Anhui Province

[Surveillance of Schistosomiasis in Zhuxi Village, Xingzi County, 2005-2010].

The analysis of surveillance results of schistosomiasis in Anhui in 2005

An economic evaluation of the national schistosomiasis control programme in China from 1992 to 2000.

[Establishment and application of rapid assessment system of environment with high transmission risk of schistosomiasis in marshland and lake regions II establishment and application of measures for field survey].

Dynamic evolution of schistosomiasis distribution under different control strategies: Results from surveillance covering 1991-2014 in Guichi, China

Analysis on national surveillance of schistosomiasis in Anhui province in 2006

Observation on comprehensive measures of safe treatment of night-soil and water supply, replacement of bovine with machine for schistosomiasis control

[National Surveillance of Schistosomiasis from 2000 to 2002].

Cost of interventions to control schistosomiasis: A systematic review of the literature

Toward sustainable and comprehensive control of schistosomiasis in China: lessons from Sichuan.

Toward Sustainable and Comprehensive Control of Schistosomiasis in China: Lessons from Sichuan

Identifying Spatial Clusters of Schistosomiasis in Anhui Province of China: A Study from the Perspective of Application.

Study on the Effectiveness of Schistosomiasis Control Via Integrated Measures Emphasizing Infection Source Control

A strategy to control transmission of Schistosoma japonicum in China.

[Assessment of Effect and Quality Control for Parasitological Tests in National Schistosomiasis Surveillance Sites].